SCHEMBL23504639

SCHEMBL23504639

c1ccc(-c2cc(-c3c4ccccc4c(-c4ccc(-c5cccc6oc7ccccc7c56)c5oc6ccccc6c45)c4ccccc34)c3ccccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.38
▸ CDC14B O60729 3/20 0.36
▸ CDC14A Q9UNH5 3/20 0.36
▸ HPGD P15428 4/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALPI P09923 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504645 0.96 CDC14B (0.36) ALOX5CDC14BCDC14AHPGDHSD17B10
SCHEMBL23504672 0.93 ALOX5 (0.46) ALOX5CDC14BCDC14AHPGDHSD17B10
SCHEMBL22062773 0.93 ALDH1A1 (0.36) HPGDHSD17B10L3MBTL1ALDH1A1TSHR
SCHEMBL23504671 0.92 ALOX5 (0.45) ALOX5CDC14BCDC14AHPGDHSD17B10
SCHEMBL22178611 0.89 CDC14B (0.36) ALOX5CDC14BCDC14AHPGDALDH1A1
SCHEMBL22087409 0.89 CDC14B (0.36) ALOX5CDC14BCDC14AHPGDALDH1A1
SCHEMBL22705821 0.89 ALDH1A1 (0.36) ALOX5HPGDHSD17B10L3MBTL1ALDH1A1
SCHEMBL22088904 0.88 ALOX5 (0.37) ALOX5CDC14BCDC14AALDH1A1MAPT
SCHEMBL23504636 0.88 HPGD (0.43) ALOX5CDC14BCDC14AHPGDHSD17B10
SCHEMBL23504604 0.86 ALOX5 (0.40) ALOX5CDC14BCDC14AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038123-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2021-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038123-B2 Compound and organic electronic device using the same CHRM1, CHRM2, C1S ALOX5 3207/4885CDC14B 3827/4885CDC14A 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback